Synaptogenix Inc (SNPX)

[Cyosol]

It's a shame they didn't include other test scores as a secondary endpoint at least.

The SIB only goes to 100 and these patients will start the trial at over 80 and even 90 in some cases, which means any non-responders will have an outsized effect on the average.

Even if the drug works as expected, they have essentially put a cap on how much of an improvement they can get.